Used together, they up the amount of oxygenated blood circulating through the body during CPR
MONDAY, March 9, 2015 (HealthDay News) — A new cardiopulmonary resuscitation (CPR) system designed to increase the chance of survival in people experiencing cardiac arrest has been approved by the U.S. Food and Drug Administration.
The ResQCPR System involves two devices used together to help people who require CPR outside the hospital. The first device, the ResQPump Active Compression Decompression CPR Device, attaches to a person’s chest with a suction cup, making it easier for a rescuer to perform compressions and decompressions, the FDA said. The second unit, the ResQPod 16.0 Impedance Threshold Device, fits onto a rescue mask or breathing tube, and helps reduce pressure inside the patient’s chest. This procedure, known as preloading, helps draw more blood to the heart.
Used together, the devices help increase the amount of oxygenated blood that circulates through the patient’s body during CPR, the FDA said.
Side effects observed during clinical testing were similar to those of standard CPR, the agency said. In addition, people using the new devices had a higher risk of pulmonary edema than people who received standard CPR.
The devices are made by Advance Circulatory Systems, based in Roseville, Minn.